 |
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a total of $46.1 million in grants to the Channing Division of Network Medicine at BWH and National Jewish Health to support the second phase (2012-2017) of the COPDGene Project. This project is the largest study ever of the genetics of COPD, which seeks to identify approaches for diagnosing, classifying and treating specific subtypes of the disease.
The grant enables scientists to build on the first phase of the COPDGene Study in analyzing the human genome comprehensively to find additional genetic predispositions to developing COPD. This research has the potential to identify the set of genes that controls susceptibility to COPD. Such information would aid the development of new therapies that could improve the quality of life for individuals with COPD - and potentially save lives. Dr. Edwin Silverman of BWH and Dr. James Crapo of National Jewish Health are the Principal Investigators of COPDGene.
